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Tuberculosis among the homeless and inmates kept in custody 
and in penitentiary institutions in the Silesia region 
Gruźlica u osób bezdomnych i u osadzonych w aresztach śledczych oraz w zakładach 
karnych województwa śląskiego
This study was financed by the Silesian Marshal’s Office in Katowice within the Regional Tuberculosis Control Programme 2011−2014
Abstract 
Introduction: There are more than 10 million prisoners in the world. Tuberculosis incidence is 10−100 times higher in 
prisoners than in the general population. Inmates have close contact with other prisoners and with prison workers and 
visitors, so tubercle bacilli may be easily spread. Most of the inmates come back to normal life and contact with the general 
population.
The aim of the study was to assess active tuberculosis incidence among prisoners and homeless persons in the Silesia region.
Material and methods: In total 897 people entered the study, of whom 720 were Silesian penitentiary system inmates, and 177 
were homeless. BACTEC MGIT fast TB detection system and GenoType Mycobacteria Direct test were used. Drug susceptibility 
testing was done using SIRE KIT and PZA KIT. 
Results: Tuberculosis was diagnosed in 13 out of 897 persons (1.45%): in 11 out of 720 inmates (1.53%) and in 2 out of 177 
homeless persons (1.13%). Data concerning drug susceptibility were obtained for 11 persons. M. tuberculosis strains isolated 
from eight persons were susceptible to four first-line antituberculosis drugs (streptomycin, isoniazid, rifampin, ethambutol), while 
M. tuberculosis strains isolated from three persons were drug-resistant. One out of three isolated strains was resistant to etham-
butol, but susceptible to streptomycin, isoniazid, rifampin, and pirazynamide. The second strain was resistant to streptomycin 
and pyrazinamide but susceptible to isoniazid, rifampin, and ethambutol. The third strain was susceptible to rifampin but resistant 
to the other four tested drugs.
According to the obtained data, culture-positive pulmonary tuberculosis was 100 times more frequent in the examined population 
than in the general population of the Silesia region in the same period of time. 
Conclusions: The health project enabled effective detection of tuberculosis in risk groups and should be continued in the following 
years. The set of the applied diagnostic methods allowed the detection of in the studied subpopulations people suffering from 
tuberculosis. Patients were treated with antituberculosis drugs that would stop them from spreading the disease to other people. 
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Streszczenie 
Wstęp: W skali globalnej w więzieniach przebywa równocześnie więcej niż 10 milionów osób. Częstość występowania gruźlicy 
u więźniów jest 10−100 razy wyższa niż w ogólnej populacji. Osadzeni kontaktują się pomiędzy sobą oraz z pracownikami i odwie-
dzającymi, co stwarza ryzyko zarażenia ich gruźlicą. Po odbyciu kary więźniowie mogą być źródłem gruźlicy dla osób z otoczenia. 
Celem pracy było określenie częstości występowania aktywnej gruźlicy u osób bezdomnych, aresztantów i więźniów w woje-
wództwie śląskim. 
Materiał metody: Badaniami objęto 897 osób, w tym 177 podopiecznych Miejskiego Ośrodka Pomocy Społecznej (MOPS) i 720 
osadzonych w zakładach penitencjarnych. W diagnostyce gruźlicy wykorzystano metody: BACTEC MGIT, MGIT TBc Identification 
Test i GenoType Mycobacteria Direct. Do określenia lekooporności prątków zastosowano zestawy SIRE KIT i PZA KIT. 
Wyniki: Gruźlicę rozpoznano u 13 spośród 897 osób (1,45%): u jedenastu osób na 720 (1,53%) osadzonych w śląskich zakładach 
penitencjarnych oraz u dwóch osób na 177 (1,13%) podopiecznych MOPS. Dane dotyczące lekooporności szczepów uzyskano 
w 11 przypadkach. Szczepy prątków gruźlicy wyhodowane od ośmiu chorych były wrażliwe na podstawowe leki przeciwprątkowe 
(streptomycyna, izoniazyd, rifampicyna, etambutol), natomiast trzy szczepy uzyskane od kolejnych chorych były oporne na leki: 
jeden — na etambutol, drugi — na streptomycynę i pirazynamid, a trzeci — na izoniazyd i etambutol. 
Uzyskane dane przemawiają za tym, że częstość gruźlicy płuc potwierdzonej badaniem bakteriologicznym była w badanej grupie 
osób 100 razy wyższa niż w populacji województwa śląskiego w tym samym okresie czasu. 
Wnioski: Realizowany program zdrowotny pozwala na efektywne wykrywanie przypadków gruźlicy w grupach ryzyka i dlatego 
powinien być kontynuowany w kolejnych latach. Zastosowany zestaw diagnostycznych metod laboratoryjnych umożliwił wy-
krycie w badanych subpopulacjach osób chorych na gruźlicę. Chorzy zostali poddani leczeniu przeciwprątkowemu, co zatrzyma 
dalsze rozprzestrzenianie się zakażenia za ich pośrednictwem.
Słowa kluczowe: gruźlica, diagnostyka, lekooporność, więźniowie, bezdomni, województwo śląskie
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Introduction
Tuberculosis (TB) has remained one of the 
most crucial health and social problems for more 
than two hundred years. The risk factors of dise-
ase are: malnutrition, restricted access to health 
care centres, aging of the societies, homelessness, 
growing migration of people, HIV infection, and 
devastating addictions to drugs or alcohol [1−3]. 
It is believed that placing a person in prison con-
stitutes a risk factor of tubercle bacilli infection [4]. 
According to a WHO report, the prevalence of in-
fectious diseases among inmates is 10 to 100 times 
higher than in the general population, which also 
applies to active TB, including multidrug-resistant 
TB [5]. Crowded prisons [6], insufficient ventilation 
of rooms, frequent rotation of inmates within the 
penitentiary and between the institutions are favo-
urable conditions for transmission of TB [7−11].
The population of inmates consists mainly 
of poorly educated young males coming from 
dysfunctional families with high incidence of 
TB [12]. At the moment of admission to prison, 
convicts are often infected and are more prone 
to the development of active TB than the general 
population [13].
On a global scale, there are over 10 million 
prisoners worldwide [7]. It is estimated that there 
are 145 inmates per 100,000 people [7, 14]. Accor-
ding to the WHO, in 1998 in Poland the prevalen-
ce of TB among prisoners was 153/100,000 [7]. Ac-
cording to Polish data, in 2008 the prevalence of 
TB in prisoners amounted to 270/100,000, i.e. 10 
times higher than in the general population [15]. 
Many reports have shown that the penitentiary 
system is a reservoir of M. tuberculosis [16−21]. 
It is difficult to compare the prevalence of TB 
between the general population and the inmates 
population as data concerning infected inmates 
are not easily available. In many countries such 
information is documented rarely or only in se-
lected penal institutions [15, 22]. An impressive 
number of published reports on TB in inmates co-
mes from the USA [23]. Prison officers who have 
developed active disease due to exposure to my-
cobacteria at work may infect other people in their 
environment. An American study in 2003 pre-
sented the results of research conducted in New 
York penitentiaries. It transpired that one-third 
of all TB cases concerned prison officers [17]. 
Whereas a study from 1997 showed that 38 
inmates and 5 prison officers were infected with 
the same strain of tubercle bacilli [18]. To con-
trol the disease, it is necessary to make a quick 
diagnosis and apply a therapy. Failure to give 
a proper diagnosis or to use effective treatment 
may lead to the transmission of the disease to 
people from outside the prison, via infected staff, 
people visiting the inmates, or those who have 
already served their time [24, 25].
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The published data have shown that the ma-
jority of correctional and detention facilities ope-
rate in such a way as to maximise public safety, 
and not to minimise the risk of transmission of 
a disease and to assure effective medical care to 
inmates [26]. The transfer of prisoners from one 
institution to another hinders diagnosis of TB, 
monitoring of treatment results, and elimination 
of the disease [26].
Molecular testing has confirmed that trans-
mission of TB between prisons significantly influ-
ences the incidence of TB among the population 
of inmates [27−29]. The health of prisoners is 
a vital element of public health [30].
Higher incidence of TB in correctional faci-
lities, mines, and hospitals may lead to the spread 
of the disease in the whole population. Therefore, 
the mentioned institutions have been called “in-
stitutional amplifiers” of TB [31, 32]. 
In many countries, activities have been un-
dertaken with the aim of preventing TB develop-
ment in penitentiaries. In Israel, researchers have 
recommended completing of a symptom question-
naire by all new inmates, and a tuberculin skin 
test (TST) for prisoners infected with HIV, drug 
addicts, and immigrants from the former Soviet 
Union [16, 33]. They also recommend checking 
for TST in prison officers, and then completing 
a symptom questionnaire after one year of em-
ployment. The best time to diagnose and treat TB 
in inmates is the moment of entering the prison 
[16, 33]. In order to reduce the incidence of TB 
in prisons, the analysis of two basic objectives 
(phases) of the disease control: early identification 
of persons with TB and effective application of 
DOTS strategy (directly observed treatment short 
course), was carried out in Bolivia, Ecuador, and 
Paraguay in the prisons that gathered the highest 
number of male inmates in the given state [34]. 
The problems in the penitentiary health care 
system, poor living conditions, failure to coordi-
nate national TB control programmes with the 
penitentiary health care system, and insufficient 
resources hinder pursuing appropriate actions 
aimed at prevention and treatment of TB [34]. 
In Brazil, it has been shown that the number of 
professional health care workers employed in the 
penitentiary system is insufficient to fulfil the 
inmates’ right to healthcare [35]. Furthermore, 
medical workers in the penitentiary system have 
been underpaid and employed on short-term 
contracts, which results in fluctuation of the 
staff [35]. 
Additionally, in recent years in Brazil the 
number of inmates has grown dramatically, 
which has made prisons the places that favour 
transmission of infectious diseases such as TB 
and HIV [36].
The homeless are also more at risk of acti-
ve TB development [3, 37−41]. It is caused by 
poor living conditions, poverty, malnutrition or 
starvation, avoidance or lack of the possibility of 
benefiting from healthcare services, unhygienic 
lifestyle, or alcohol addiction. According to some 
researchers, homelessness is one of the greatest 
risk factors for acquiring latent TB infection and 
active TB [38]. Such an opinion has been con-
firmed by the results of research conducted in 
many countries, among others in Canada [37], 
Israel [33], Italy [42, 43], and the USA [38, 39, 44]. 
The Polish study of Jagodziński et al. reviewed 
the documentation of 300 patients hospitalised 
between 2004 and 2006 on a male ward of the 
Mazovian Centre for Treatment of Lung Dise-
ases and Tuberculosis in Otwock. In total, 74% 
of sputum-positive patients hospitalised in the 
Mazowsze region were professionally inactive, 
57% of them were unemployed, and 10% were 
homeless [40]. 
The objective of the present study was to 
identify TB in homeless charges of the Municipal 
Social Assistance Centre (MOPS, Miejski Ośrodek 
Pomocy Społecznej) and in detainees and inmates 
in the Silesia region. 
Material and methods 
Centres conducting microbiological tests. 
The tests were performed in Zabrze in the Labo-
ratory of Tuberculosis Bacteriology, Independent 
Public Teaching Hospital No. 3, Medical Uni-
versity of Silesia in Katowice, in the Laboratory 
of Bacteriology, Hospital of Lung Diseases in 
Orzesze, and in the Laboratory of Bacteriology, 
Central Laboratory of the Regional Health Centre 
in Katowice.
Characteristics of the study groups. A total 
of 897 subjects entered the study, including 720 
detainees from five Silesian detention facilities (in 
Bielsko-Biała, Katowice, Mysłowice, Sosnowiec, 
and Zabrze), and from two correctional facilities 
(in Jastrzębie Zdrój and Zabrze) and 177 charges 
of the Municipal Social Assistance Centre (MOPS) 
in Katowice (4 local points in the city). 
We examined the persons who were serving 
their sentence in the penitentiary or staying in 
MOPS (not at the moment of their admission to 
the mentioned institutions). The main idea of 
the project was to conduct microbiological TB 
tests in as many inmates and charges of MOPS as 
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Table 1. Sex structure of the studied population
Institution Number of persons
Women Men Total
Penitentiary/Prison 54 662 716
Municipal Social Assistance 
Centre/Homeless shelters
47 114 161
Total 101 776 877*
*Data about sex were obtained for 877 persons (97.8%) out of the 897 exami-
ned subjects
Table 2. Age structure of the studied population
Statistical indicator/Institution Penitentiary/Prison Municipal Social Assistance Centre/ 
/Homeless shelters
Total
Arithmetic mean 37.77 49.01 39.83*
Standard deviation 12.25 14.25 13.36
Minimum 16 18 16
Maximum 72 84 84
*Data about age were obtained for 877 persons (97.8%) out of the 897 examined subjects
possible. Sputum samples were collected between 
September and November, 2012. 
Selected subpopulations were described in 
respect of age and sex. Information about 877 
subjects was obtained, representing 97.8% of 
the examined population. Men made up 88.5% 
of the study group, whereas women made up 
11.5% (Table 1).
The study subjects ranged in age from 16 to 84 
years, and the mean age was 39.83 years (Table 2). 
The subjects from correctional and detention 
facilities were younger (37.77 years) than the 
charges of the MOPS centres — the mean age in 
this subpopulation amounted to 49.01 years.
The study subjects were qualified for the 
examination by medical services from their home 
institutions, i.e. detention and correctional faci-
lities (under the direction of the Chief Physician 
of the Regional Inspectorate of Prison Officers 
(OISW, Okręgowy Inspektorat Służby Więziennej) 
in Katowice) and MOPS in Katowice. The medi-
cal services of the institutions participating in 
the project (Municipal Social Assistance Centre, 
correctional/detention facility) took part in col-
lecting sputum samples and preparing the list of 
the examined subjects, and in cases when TB was 
diagnosed their charges were sent for specialised 
treatment.
We applied five basic diagnostic methods 
that were appropriate for the clinical material, 
the stage of the research, the diagnostic objecti-
ve, the and technical possibilities of the centres 
participating in the project. 
Collected sputa were decontaminated by the 
NALC/NaOH method. From each decontaminated 
sputum two microscopic specimens were made, 
which then underwent direct Ziehl-Neelsen sta-
ining; cultures on solid media (classic method) 
and liquid media (rapid method) were performed. 
In the case of a positive result of a direct test 
and in clinically justified cases, DNA or RNA 
(depending on the equipment of the laboratory) 
were isolated, and a genetic method allowing the 
identification of M. tuberculosis in the clinical 
material was used.
In the case of identification of tubercle bacilli 
in the clinical material, the drug susceptibility of 
the cultured strains was assessed. 
Based on the obtained drug susceptibility, 
antituberculosis chemotherapy was introduced.
Every identified case of TB was reported to 
the relevant medical services (MOPS, correc-
tional/detention facility) and relevant Regional 
Sanitary-Epidemiological Station. The subjects 
suffering from the disease were hospitalised and 
treated in specialised healthcare centres.
Results
Tubercle bacilli were found in the clinical 
material collected from 13 out of 897 subjects 
included in the project (1.45%). 
M. tuberculosis colonies have been cultu-
red from the clinical material collected from 
13 persons, in whom mycobacteria were first 
found using methods other than culture. Using 
BACTEC MGIT system and/or classic method of 
solid culture, colonies of tubercle bacilli were 
obtained from sputum collected in 11 men out 
of 707 inmates from correctional/detention fa-
cilities (1.53%) and from sputum of 2 men out 
of 177 examined charges of the MOPS (1.13%) 
(Tables 3, 4). The obtained positive results of the 
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Table 3. Results of diagnostic tests depending on the applied method
Methods  Results
 Positive  Negative Total
Culture 13 (1.37%*)  871 (91.98%)  884 (93.35%)**
Susceptibility testing  11 ( 1.16%)
Genetic tests — DNA, RNA 9 (0.95%)  43 (4.54%)  52 (5.49%)
Total number of analyses 947 (100%)
*Percentage of total number of analyses 
**Data about the results of 884 cultures were obtained
Table 4. Results of diagnostics performed using cultures and genetic methods in the studied subpopulations
Results/Methods Penitentiary/Prison Municipal Social Assistance Centre/ 
/Homeless shelters
Positive Negative Total Positive Negative Total
Culture 11* (1.40%**) 696 (88.21%) 707*** (89.61%) 2 (1.11%) 175 (97.22%) 177*** (98.33%)
Genetic tests — DNA, RNA 9 (1.14%) 43 (5.45%) 52 (6.59%) − − −
*Number of the results of analyses 
**Percentage of total analyses 
***Data about the results of 884 cultures were obtained
culture were verified by other methods (e.g. MGIT 
TBc Identification Test, niacin test, GenoType 
Mycobacteria Direct). Drug susceptibility of iso-
lated tubercle bacilli strains was assessed in 11 
patients. Eight strains were susceptible to basic 
anti-TB drugs (SIRE, PZA). Among three strains of 
tubercle bacilli that were resistant to one or more 
first-line anti-TB drugs, one strain was resistant 
to ethambutol, one strain — to streptomycin and 
pyrazinamide, and one strain — to all tested drugs 
apart from rifampicin. 
Discussion
The frequency of active TB in inmates is usu-
ally several or several-dozen times higher than in 
the general population, both in developing and 
developed countries [45−48]. In some regions 
of the world the situation may deteriorate [49]. 
In Europe and Central Asia, a relation between 
increased number of prisoners, TB incidence, 
and multi-drug resistant TB (MDR TB) has been 
shown [49].
According to the Bulletin of the National 
Institute of Tuberculosis and Lung Diseases, the 
number of patients diagnosed with all forms of TB 
in Poland in 2012, i.e. during the project, was 7542, 
with the incidence rate of 19.6 per 100,000 [50]. 
5070 cases of TB were bacteriologically confirmed 
(an incidence rate of 13.2/100,000). In the same 
year in the Silesia region, the number of patients 
diagnosed with of all forms of TB amounted to 
1185, with an incidence rate of 25.6/100,000. 
759 cases were confirmed bacteriologically (an 
incidence rate of 16.4/100,000). 
The incidence rate of TB for the populations 
of inmates and homeless people taking part in the 
project, calculated basing on the obtained results 
of the present study, was markedly higher com-
pared to the respective coefficients for the state 
and the region (Table 5).
The objective of the study was to identify sub-
jects with pulmonary TB. In Poland in 2012, the 
number of patients registered with pulmonary TB 
was 7018, the incidence rate was 18.2/100,000 [50]. 
Of these, 4870 cases were bacteriologically 
confirmed (an incidence rate of 12.6/100,000). 
According to the results of the present study, 
prisoners and charges of MOPS with active pul-
monary TB represented 1.45% of the examined 
population; the incidence rate of active pulmo-
nary TB was 1449 per 100,000: 1527/100 000 in 
prisoners and 1129.9/100 000 in the charges of 
MOPS. Tubercle bacilli were cultured exclusively 
from sputum collected from men. Tubercle bacilli 
were not cultured in any of the 101 examined 
women. This observation is in accordance with 
the data from the Institute of Tuberculosis, which 
has confirmed that the incidence of TB is higher 
in men than it is in women [50]. Assuming that 
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Table 5. Tuberculosis cases and tuberculosis notification rates in the groups of people studied in 2012. Rates per 100,000 
population
Groups Number of studied persons Number of TB cases Tuberculosis notification rates
Penitentiary/Prison 720 11 1527.78
Municipal Social Assistance Centre/ 
/Homeless shelters
177 2 1129.94
Total 897 13 1449.2
every undiagnosed and untreated person infects 
9 healthy people (in the case of inmates: in pri-
son, and after release from the prison among 
the general population), it should be stated that 
identification of 13 infected and sputum positive 
individuals is a remarkable achievement that has 
markedly decreased the probability of transmis-
sion of the disease. 
During the WHO conference on TB and HIV 
infection in Europe, one of the main issues was a 
unified strategy for treating the diseases [51, 52]. 
One of the recent review articles from PLoS ONE 
has given a lot of information about the efforts 
made by the WHO and other organisations and 
services to combat TB in prisons [21]. It has pu-
blished precise instructions on how to control 
and prevent TB in correctional facilities [21]. In 
Poland, guidelines for diagnosing and control-
ling TB are periodically published by the Polish 
Society of Lung Diseases [53]. The National TB 
Reference Laboratory in Warsaw controls perio-
dically subordinated laboratories regarding the 
quality of performed tests for TB. Local institu-
tions of different rank draw up and introduce 
projects such as regional TB control programmes 
to prevent active TB development among the most 
threatened social groups. 
Conclusions
Tests for active M. tuberculosis infection 
conducted in the Silesia region in a group of 177 
charges of the Municipal Social Assistance Centre 
and 720 inmates and detainees have allowed the 
identification of 13 persons with TB, including 2 
homeless people and 11 inmates. The applied set 
of laboratory diagnostic methods enabled effecti-
ve identification of persons with active TB. The 
persons infected have undergone antituberculosis 
treatment, which has prevented further spread of 
the disease. The obtained results have shown the 
urgent need for further studies in the groups that 
are particularly exposed to TB. 
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